Polaris Market Research presents its latest market research report, titled AI in Genomics Market Size, Share, Trends & Forecast Report, 2026-2034. It is a comprehensive market research report analyzing the fast-evolving AI in genomics market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the AI in genomics market and its outlook during the forecast period.
AI in Genomics Market Key Takeaways
- The AI in genomics market size was valued at USD 1.04 billion in 2025.
- The market is estimated to reach USD 21.08 billion by 2034.
- The market is projected to witness a CAGR of 39.74% from 2026 to 2034.
- The software segment held 50.0% of the market share in 2025.
- The population genomics segment is likely to grow at a 40.8% CAGR during the forecast period.
- The North America region held 43.0% of market share in 2025.
- The Asia Pacific region is expected to grow at a 41.5% CAGR from 2026 to 2034.
What is AI in Genomics Market?
The AI in genomics market covers software, services, and cloud platforms that apply artificial intelligence to genomic data analysis, variant interpretation, and precision medicine. Rising genomic sequencing activity and demand for computational genomics tools are driving market growth, expanding market size and market share across research institutes, hospitals, and biopharmaceutical companies worldwide.
Market Dynamics
The report examines the key market dynamics influencing the growth and development of the AI in genomics market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.
Key Market Driver: Rising Adoption of Precision Medicine
Precision medicine is increasing demand for advanced genomic analysis tools across healthcare and research institutions. AI solutions help healthcare providers with disease risk assessment, personalized treatment strategies, and improved patient outcomes. Increasing acceptance of genetic testing and biomarker-based therapies is generating substantial volumes of genomic data that require advanced analytics, positioning precision medicine adoption as a primary driver of market growth through the forecast period.
Market Opportunity: Expansion into Regenerative Medicine and Multi-Omics Research
Rising adoption of regenerative medicine, precision medicine, and organoid-based research is opening new business opportunities for AI in genomics vendors. Advanced AI applications are enabling scientists to identify genetic targets and improve predictions about treatment outcomes and drug discovery efficiency. Growing commercialization of organoids and expanding multi-omics research initiatives are expected to generate additional demand for genomics analytics platforms in the coming years, supporting long-term market expansion.
Emerging Market Trend: Genomic Data Expansion and AI Algorithm Advancements
Increasing genomic sequencing activity is contributing to rising demand for AI-enabled data analytics systems, as research labs and healthcare centers accumulate large volumes of genomic data requiring processing. Continuous advancements in machine learning algorithms are improving genomic analysis accuracy and making it easier to discover genetic patterns and disease biomarkers. Industry initiatives promoting responsible AI use in genomics research are further shaping this emerging trend across the industry.
Market Challenge: Data Privacy and Skilled Workforce Constraints
Privacy issues and compliance requirements continue to hinder AI in genomics market development, as genomic data includes sensitive patient information that must be stored and processed securely. Differences in regulatory frameworks across countries create additional challenges for technology vendors operating globally. High costs of system integration and a shortage of qualified specialists further limit adoption among smaller research organizations and healthcare providers seeking to implement genomics AI solutions.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :
https://www.polarismarketresearch.com/industry-analysis/ai-in-genomics-market
How Is Market Segmentation Done?
The research gives an in-depth segmental analysis of the AI in genomics industry. The segmentation in the market has been done on the basis of offering (software, services, and cloud platforms), application (variant interpretation, population genomics, drug target discovery, clinical diagnostics, and precision medicine), and end user (research institutes, hospitals, biopharmaceutical companies, and diagnostic laboratories). This research assesses the contribution of each segment and pinpoints the segments driving the present-day demand and those that will grow strongly during the forecast period. This analysis helps stakeholders analyze evolving demand trends and recognize promising market opportunities.
Which Region Leads Market Demand?
The report includes a regional analysis of the AI in genomics market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market dominates the overall market, attributed to advanced healthcare facilities, strong adoption of genomic technologies, and significant research funding, with the U.S. remaining the largest contributor owing to genomic research and precision medicine programs. Further, the Asia Pacific market is expected to witness significant growth during the forecast period, influenced by rising genomics investments, expanding healthcare infrastructure, and government-backed sequencing programs across countries such as China, Japan, and India. In addition to this, there is an analysis of regional demand, investments, infrastructure, regulatory environment, technology penetration, and industry development.
Who Are the Key Market Players?
The report presents a detailed competitive analysis of the AI in genomics industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.
A few of the key players in the market include:
- Illumina, Inc.
- NVIDIA Corporation
- Google DeepMind
- Tempus AI, Inc.
- Fabric Genomics, Inc.
- SOPHiA GENETICS SA
- DNAnexus, Inc.
Future Outlook
The AI in genomics market is projected to grow and evolve until the forecast year 2034 as demand grows, applications widen, and industry players respond to changing demands. Growing adoption of precision medicine, increasing genome sequencing activity, and expanding use of artificial intelligence in medical research are expected to drive market development. Long-term opportunities are anticipated to emerge from regenerative medicine, organoid commercialization, multi-omics research, and AI-assisted drug discovery, enabling stakeholders to understand developments likely to shape the market during the forecast period.
More Trending Latest Reports By Polaris Market Research:
battery-energy-storage-system-market
top-10-virtual-desktop-infrastructure-vdi-companies-software-2025
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek